I should have added to my post that it's nice to see the immune data, it is important. However, to be a real product, it all depends on the clinical data. Is there no counter view to mine on the concerns with the interim clinical data? If not, I will wait on the final data.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
24.5¢ |
Change
-0.005(2.00%) |
Mkt cap ! $357.7M | |||
| Open | High | Low | Value | Volume |
| 25.0¢ | 25.0¢ | 24.0¢ | $419.2K | 1.737M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 301706 | 24.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.5¢ | 28117 | 2 |
View Market Depth
| Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
| IMM (ASX) Chart |